Alexander J. Dwyer

发表

Programmed Death-1 Restrains the Germinal Center in Type 1 Diabetes

Jason S. Mitchell, K. Hogquist, N. Sahli, 2019, The Journal of Immunology.

Enhanced CD4+ and CD8+ T cell infiltrate within convex hull defined pancreatic islet borders as autoimmune diabetes progresses

Jason S. Mitchell, C. Tucker, B. Fife, 2021, Scientific Reports.

The Role of Programmed Death-1 in Type 1 Diabetes

C. Tucker, B. Fife, T. Martinov, 2021, Current Diabetes Reports.

Adoptive T Cell Therapy with IL-12–Preconditioned Low-Avidity T Cells Prevents Exhaustion and Results in Enhanced T Cell Activation, Enhanced Tumor Clearance, and Decreased Risk for Autoimmunity

Jason S. Mitchell, L. Beura, Tijana Martinov, 2020, The Journal of Immunology.

Increased β-cell proliferation before immune cell invasion prevents progression of type 1 diabetes

Richard D. Smith, W. Qian, E. Dirice, 2019, Nature Metabolism.

Increased β-cell proliferation before immune cell invasion prevents progression of type 1 diabetes

E. Dirice, S. Kahraman, Jiang Hu, 2019, Nature Metabolism.

Insulin B peptide-MHC class II-specific chimeric antigen receptor-Tregs prevent autoimmune diabetes

Jason S. Mitchell, M. Levings, P. Orban, 2023, bioRxiv.

Tregs with an MHC class II peptide–specific chimeric antigen receptor prevent autoimmune diabetes in mice

Jason S. Mitchell, M. Levings, P. Orban, 2023, The Journal of clinical investigation.

CD4+ T cells reactive to a hybrid peptide from insulin-chromogranin A adopt a distinct effector fate and are pathogenic in autoimmune diabetes.

T. Kaisho, Justin A. Spanier, B. Fife, 2024, Immunity.

Antigen-specific T cell responses in autoimmune diabetes

B. Fife, Alexander J. Dwyer, Zachary R. Shaheen, 2024, Frontiers in immunology.